Dr Yue Zhao speaks to ecancer about unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer.

This is a review from SIOG (International Society of Geriatric Oncology) translational working group.

Liquid biopsy is a noninvasive method that analyses circulating tumour DNA and cells.

It is crucial for adults with cancer, especially the elderly. It aids in early detection, treatment monitoring, and response assessment.

Recent studies highlight its role in improving diagnosis accuracy and personalised treatment.

The review discusses integrating liquid biopsy with geriatric assessments, challenges with age-related mutations, and the importance of public awareness in cancer care.